[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=63925]], camposKey:0365-6691 2022-01-01 Depósitos prerretinianos tipo estalagmita en la tomografía de coherencia óptica de dos pacientes vitrectomizados con panuveítis104108, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53809]], camposKey:1040-5488 2018-01-01 Fluorescein angiography indications: Changes after optical coherence tomography and antiangiogenics435442, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10063]], camposKey:1471-2415 2017-01-01 Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39310]], camposKey:0146-0404 2016-01-01 PREDICTIVE MODELS OF LONG-TERM ANATOMIC OUTCOME IN EXUDATIVE AMD TREATED WITH AS-NEEDED RANIBIZUMAB00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10093]], camposKey:2090-004X 2015-01-01 Loss of Visual Acuity after Successful Surgery for Macula-On Rhegmatogenous Retinal Detachment in a Prospective Multicentre Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10064]], camposKey:0146-0404 2015-01-01 PREDICTIVE FACTORS OF VISUAL IMPROVEMENT IN EXUDATIVE AMD PATIENTS AFTER 4 YEARS OF AS NEEDED RANIBIZUMAB TREATMENT00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39311]], camposKey:0146-0404 2015-01-01 WAVEFRONT ANALYSIS OF HIGHER-ORDER ABERRATIONS IN PATIENTS WITH HIGH MYOPIA00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10089]], camposKey:1471-2415 2014-01-01 Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49491]], camposKey:2168-6165 2014-01-01 Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration528534, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10100]], camposKey:0030-3755 2013-01-01 A New Manual Retinal Thickness Measurement Protocol to Evaluate High Myopia Patients121125, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10048]], camposKey:2090-004X 2013-01-01 Autofluorescence Images with Carl Zeiss versus Topcon Eye Fundus Camera: A Comparative Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52946]], camposKey:0365-6691 2013-01-01 Evolucion clinica de pacientes con degeneracion macular asociada a la edad de tipo exudativo-hemorragico tratados con ranibizumab. Estudio Eye2Eye.
Clinical course of patients with exudative-haemorrhagic age-related macular degeneration treated with ranibizumab. Eye2Eye study.216222, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10098]], camposKey:0275-004X 2013-01-01 External validation of existing formulas to predict the risk of developing proliferative vitreoretinopathy: The retina 1 project; Report 515191527, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53046]], camposKey:1927-6990 2013-01-01 General Practitioners' knowledge gaps regarding Age Related Macular Degeneration and effectiveness of their e-learning training3747, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10083]], camposKey:0271-3683 2013-01-01 Ocular Pain After Intravitreal Injection278282, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10102]], camposKey:1932-6203 2013-01-01 The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52947]], camposKey:0146-0404 2013-01-01 Visual loss in retinal detachment and macula-on after successful surgery, Retina 1 project00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10092]], camposKey:1120-6721 2012-01-01 A propensity score matching application: indications and results of adding scleral buckle to vitrectomy: The Retina 1 Project: Report 3244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10066]], camposKey:0308-0110 2012-01-01 E-learning strategies to improve general practitioners' knowledge of age-related macular degeneration517518, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10085]], camposKey:0030-3755 2012-01-01 Pathology Associated with Optical Coherence Tomography Macular Bending due to either Dome-Shaped Macula or Inferior Staphyloma in Myopic Patients712, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10077]], camposKey:0030-3755 2012-01-01 Retinal Pigment Epithelium Tears in Age-Related Macular Degeneration Treated with Antiangiogenic Drugs: A Controlled Study with Long Follow-Up7883, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52969]], camposKey:2090-5688 2012-01-01 Variations in Functional and Anatomical Outcomes and in Proliferative Vitreoretinopathy Rate along a Prospective Collaborative Study on Primary Rhegmatogenous Retinal Detachments: The Retina 1 Project-Report 4.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10086]], camposKey:0161-6420 2011-01-01 Sjogren-Larsson Syndrome21012102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11669]], camposKey:1177-5467 2011-01-01 Training and professional profile of retinologists in Spain: Retina 2 project, Report 4483490, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10096]], camposKey:0161-6420 2010-01-01 A Strong Genetic Association between the Tumor Necrosis Factor Locus and Proliferative Vitreoretinopathy: The Retina 4 Project24172423, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40837]], camposKey:1938-2375 2010-01-01 Benign fleck retinal findings on multifocal ERG, microperimetry, and OCT.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50860]], camposKey:1560-2133 2010-01-01 Choroidal neovascularisation in punctate inner choroidopathy: therapeutic options.1928, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10058]], camposKey:1120-6721 2010-01-01 PRPH2 (Peripherin/RDS) mutations associated with different macular dystrophies in a Spanish population: a new mutation724732, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54146]], camposKey:0007-1161 2009-02-01 Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation166170, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49622]], camposKey:0146-0404 2009-01-01 Development of predictive models of proliferative vitreoretinopathy based on genetic variables: The retina 4 project23842390, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11671]], camposKey:0365-6691 2009-01-01 Formación y actividad clínica de los retinólogos en españa: Un primer acercamiento. Proyecto retina 2. Análisis descriptivo Training and clinical activity of Spanish retinologists: A preliminary approach. Retina 2 project. Descriptive analysis7584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54145]], camposKey:0277-3740 2008-02-01 Ocular toxicity caused by toad venom236237, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53052]], camposKey:0146-0404 2008-01-01 Analysis of Peripherin-rds in Isolated Cases and Spanish Families Presenting Different Macular Dystrophies00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53042]], camposKey:0146-0404 2008-01-01 Anatomical and Functional Outcomes After Surgery for Primary Rhegmatogenous Retinal Detachments (RD) in Phakic and Pseudophakic Patients. Preliminary Results of a Multicentric Prospective Study: The Retina 1 Project52405240, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10069]], camposKey:0007-1161 2008-01-01 Non-complicated retinal detachment management: variations in 4 years. Retina 1 project; report 1523525, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52967]], camposKey:1935-1089 2008-01-01 Oct findings in torpedo maculopathy109111, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10090]], camposKey:0007-1161 2008-01-01 Surgical outcomes for primary rhegmatogenous retinal detachments in phakic and pseudophakic patients: the Retina 1 Project - report 2378382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10070]], camposKey:1542-8877 2007-01-01 Atypical myopic retinoschisis157159, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10081]], camposKey:0927-3948 2007-01-01 Photodynamic therapy for subfoveal and juxtafoveal choroidal neovascularization associated with punctate inner choroidopathy2729, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39632]], camposKey:1395-3907 2006-01-01 Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: a preliminary study309313, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10099]], camposKey:1395-3907 2006-01-01 Photodynamic therapy in subfoveal and juxtafoveal idiopathic and postinflammatory choroidal neovascularization743748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10387]], camposKey:0271-3683 2005-01-01 Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy147153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13967]], camposKey:0365-6691 2004-01-01 Estudio experimental sobre la utilidad del aceite de copolímero de silicona-fluorsilicona (SiFO) en la cirugía vitreorretiniana205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49631]], camposKey:0365-6691 2004-01-01 Experimental study on usefulness of silicone-fluorsilicone copolymer oil (SiFO) in vitreoretinal surgery Estudio experimental sobre la utilidad del aceite de copolímero de silicona-fluorsilicona (SiFO) en la cirugía vitreorretiniana.205212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49634]], camposKey:0365-6691 2003-01-01 Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study Factores clínicos de riesgo para el desarrollo de la vitreorretinopatía proliferante (VRP) postquirúrgica. Estudio prospectivo.9197, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=13969]], camposKey:0365-6691 2003-01-01 ¿Puede aumentar el riesgo de oftalmía simpática el uso intraocular de aceite de silicona?3942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=10383]], camposKey:0146-0404 2002-01-01 Clinical risk factors of proliferative vitreoretinopathy (PVR). A case-control and multicentric study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54147]], camposKey:0146-0404 2001-03-15 Is silicone oil intraocularly injected related to a higher prevalence of sympathetic ophthalmia?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69952]], camposKey:0365-6691 1989-01-01 Diagnóstico de las drusas de papila.543548, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69963]], camposKey:0365-6691 1989-01-01 Gliomas ópticos. Estudio clínico-evolutivo de 17 casos.393400, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69949]], camposKey:0365-6691 1989-01-01 Levobunolol comparado con Timolol en el tratamiento del glaucoma crónico de ángulo abierto e hipertensión ocular.463468, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69961]], camposKey:0365-6691 1988-01-01 Complicaciones de la extracción extracapsular de cataratas por cirujanos principiantes en esta técnica.419426, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69957]], camposKey:0365-6691 1988-01-01 El uso del gas intraocular como complemento en el tratamiento de ciertos desprendimientos de retina.853858, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69956]], camposKey:0365-6691 1988-01-01 Evaluación del "Score " de Mintz-Hittner en la predicción de retinopatía de la prematuridad apartir de sus factores de riesgo.769774, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69955]], camposKey:0365-6691 1988-01-01 Quiste de iris tratado con láser YAG613618, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69962]], camposKey:0365-6691 1988-01-01 36 casos de hipertrofias congénitas del epitelio pigmentario y poliposis cólica familiar.209214, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69950]], camposKey:0365-6691 1987-01-01 Angiofluoresceíngrafía vía oral: ventajas e inconvenientes.445450, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69951]], camposKey:0365-6691 1987-01-01 Cuerpos extraños intracristalinianos con cristalino claro.167172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69964]], camposKey:0365-6691 1987-01-01 Engrosamiento de los nervios corneales: valor diagnóstico en el síndrome endocrino MEN II-B173178, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69954]], camposKey:0365-6691 1987-01-01 Refracción residual en la pseudofaquia: factores influyentes. Su determinación.6184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69953]], camposKey:0365-6691 1987-01-01 Retroinserción bimedial simétrica: Diez años de experiencia.697710, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69960]], camposKey:0365-6691 1986-01-01 La coroidopatía macular hemorrágica juvenil: Estudio de 49 casos.355366, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69959]], camposKey:0365-6691 1986-01-01 Poliposis Cólica Familiar y Síndrome de Gardner: valor diagnóstico de las manifestaciones oculares.505514, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69958]], camposKey:0365-6691 1986-01-01 Tratamiento quirúrgico del glaucoma neovascular. Estudio comparativo de las técnicas quirúrgicas últimamente utilizadas. Implantes filtrantes.5766][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19669]},camposKey: 97 99 Endoftalmitis luética en paciente con implante intravítreo de dexametasona 978-84-16269-41-9Casos clínicos en oftalmología II: Problemas diagnósticos en patología retinocoroidea 1 2018-01-01 Euromedice Vivactis, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19157]},camposKey: 319 335 Enfermedades Hereditarias de los Conos 978-84-89085-44-2PATOLOGÍA Y CIRUGÍA DE LA MÁCULA 1 2010-01-01 Sociedad Española de Oftalmología][][][][][][][][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@65160a][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c3836], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@465521], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@46595b], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@467c25], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414d42], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413397], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4136a9]][][][][][][][]